Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the launch of their LV Edge Packaging System, which improves the cost efficiency and reduces ...

As lentiviral vector (LVV) programs advance toward larger clinical trials and commercialization, manufacturing platforms and ...

In the manufacturing of lentivirus vectors for cell and gene therapy applications, GMP-grade plasmids account for a significant proportion of the raw material costs. The procurement of these plasmids ...